CIBC Private Wealth Group LLC Has $579,000 Holdings in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU)

CIBC Private Wealth Group LLC lessened its position in shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABUFree Report) by 95.0% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 4,750 shares of the company’s stock after selling 90,250 shares during the quarter. CIBC Private Wealth Group LLC’s holdings in Direxion Daily S&P Biotech Bull 3x Shares were worth $579,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Second Half Financial Partners LLC acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter worth approximately $40,000. Formidable Asset Management LLC grew its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 17.5% during the 3rd quarter. Formidable Asset Management LLC now owns 40,231 shares of the company’s stock worth $153,000 after buying an additional 6,001 shares during the period. Traynor Capital Management Inc. acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 4th quarter worth approximately $325,000. Gateway Advisory LLC acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 4th quarter worth approximately $366,000. Finally, Pathstone Family Office LLC acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter worth approximately $439,000.

Direxion Daily S&P Biotech Bull 3x Shares Stock Up 2.1 %

Shares of LABU stock opened at $112.43 on Tuesday. Direxion Daily S&P Biotech Bull 3x Shares has a 52 week low of $48.40 and a 52 week high of $176.99. The firm has a 50 day moving average of $105.13 and a 200-day moving average of $115.56.

Direxion Daily S&P Biotech Bull 3x Shares Profile

(Free Report)

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.

Further Reading

Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABUFree Report).

Institutional Ownership by Quarter for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU)

Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.